Perfectus

NAMSA Acquires UK-Based Perfectus Biomed Group to Enhance Customized Microbiological Solutions

Retrieved on: 
Tuesday, October 4, 2022
Medical Devices, Health, Science, Other Science, Research, Solution, Microbiology, Technology, Industry, Perfectus, Research, Knowledge, Medtech, Multimedia, CRO, Accreditation, Quality of life, UKAS, Acquisition, Laboratory, Health, Contract research organization, Fine chemical, Medical device

NAMSA , a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group , a UK-based laboratory providing customized microbiological services.

Key Points: 
  • NAMSA , a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group , a UK-based laboratory providing customized microbiological services.
  • NAMSA very much looks forward to expanding its European suite of laboratory services with the addition of Perfectus Biomed Group, commented Dr. Christophe Berthoux , NAMSA CEO.
  • Perfectus brings an unmatched level of expertise and depth of knowledge in customized microbiological testing solutions.
  • Perfectus Biomed Group is delighted to join NAMSA in its mission to deliver best-in-class global MedTech solutions through its people, expertise and technology.